AVE 16.7% 0.3¢ avecho biotechnology limited

technical picture only, page-12

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    WL,

    IF SCE have said it another way let me know

    In the report they gave 17 examples of past deals which included up-front and royalty payments. 3 or 4 appear to be up-front payments of $100mil+ with the rest being anywhere down from there. $10mill up-front would actually be a very low example based on the examples they gave in the report, but regardless even if it was a $10mill up-front payment, that payment alone for one application (excluding milestones and royalties) would support the company's current marketcap.

    Bottom line is if we believe the TPM technology works then it is only a matter of time before the up-front component of any deal announced will push this to much higher levels.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $3.461K 1.175M

Buyers (Bids)

No. Vol. Price($)
65 101062608 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20323507 8
View Market Depth
Last trade - 15.44pm 16/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.